CNSY
Plus Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$2.78
−6.71%Margins
Gross margin
89.6%
EBITDA margin
-532.7%
EBIT margin
-628.1%
Net margin
-620.7%
FCF margin
-560.3%
-477.5%
Return on equity
-185.9%
Return on assets
-479.4%
Return on invested capital
0.25x
Asset turnover
-$22.2M
Cash from operations
$1.13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026